• Ouabain: A Translational Ion-Transport Lens

  2026-09-03

  Ouabain is more than a classic pump inhibitor: it is a mechanistic probe linking extracellular Na+/K+-ATPase engagement to intracellular sodium, calcium handling, cardiovascular physiology, and emerging senescence biology. This article presents an evidence-aware framework for assay design, translational interpretation, and strategic use of Ouabain in cardiovascular and ion-transport research.

• C8-HSL Drives Lung Cancer via PI3K/AKT/ERK

  2026-09-03

  The 2026 FASEB Journal study identifies the bacterial quorum-sensing molecule C8-HSL as a previously unrecognized regulator of lung cancer cell behavior. Using H460 cells and in vivo validation, the authors link C8-HSL exposure to PI3K/AKT/ERK activation, cell-cycle progression, migration, and invasion, while highlighting important limits for clinical interpretation.

• Nadolol (SQ-11725): From β-Blockade to PK Insight

  2026-09-02

  Nadolol (SQ-11725) is more than a conventional beta-blocker research reagent. Its non-selective receptor antagonism provides a practical way to interrogate the beta-adrenergic signaling pathway, while its transporter biology creates a bridge to pharmacokinetic and tissue-distribution studies. This thought-leadership guide outlines experimental design, translational limits, and strategic applications across hypertension research, angina pectoris studies, and vascular headache research.

• Octyl-α-ketoglutarate in HIF-1α Research

  2026-09-02

  Learn how Octyl-α-ketoglutarate can function as a cell-permeable prolyl hydroxylase substrate in HIF-1α, TCA-cycle, and IDH models. This workflow-focused guide covers rescue experiments, assay controls, dosing strategy, and troubleshooting for separating α-ketoglutarate availability from oxygen-dependent hypoxia signaling.

• GSK2606414: A Translational PERK Strategy

  2026-09-01

  GSK2606414 offers a precise way to test whether PERK-dependent translational control drives disease phenotypes. This thought-leadership guide connects its mechanism and selectivity with ER stress research, liver disease, cancer research, and translational study design.

• Gefitinib (ZD1839) for EGFR Workflow Design

  2026-09-01

  Build reproducible Gefitinib workflows for target engagement, cell-cycle analysis, apoptosis, and resistance studies. This guide also translates a blue-light skin-barrier study into a carefully bounded EGFR-mechanism assay without overstating cross-domain evidence.

• BMS 309403: FABP4 Inhibitor Workflow

  2026-08-31

  BMS 309403 is a direct, selective FABP4 probe for connecting fatty acid handling with macrophage inflammation, foam cell formation, and metabolic signaling. This practical guide translates recent SERCA2–calcineurin–FoxO1–FABP4 findings into cell-based workflows, controls, and troubleshooting strategies.

• Ibotenic Acid Toxicity in Mice: Dose and Time

  2026-08-30

  A 2026 murine study provides a structured analysis of ibotenic acid toxicity across dose and exposure time, linking behavioral changes with biochemical disruption, early c-fos activation, and reduced Nissl bodies. The findings refine interpretation of this NMDA receptor agonist in toxicology and neuroscience by separating reversible acute responses from high-dose neuronal injury.

• NBC19: NLRP3 Inflammasome Inhibitor Guide

  2026-08-29

  NBC19 is a nanomolar research tool for separating NLRP3-driven IL-1β signaling from broader macrophage inflammatory programs. This workflow-focused guide shows how to use it in THP-1 assays, compare Nigericin and ATP triggers, and cautiously connect inflammasome data with lactate-HMGB1 biology.

• Fluoxetine HCl and the Motivation Circuit

  2026-08-29

  Fluoxetine HCl is more than a standard serotonergic probe: it can anchor a translational workflow linking serotonin transporter biology, 5HT2C signaling, plasticity, and motivation-specific behavioral phenotypes. This thought-leadership guide interprets developmental SSRI findings, defines practical assay parameters, and outlines how researchers can use fluoxetine to test circuit-level hypotheses without overstating what a molecular perturbation proves.

• ECL Western Blotting Substrate: Practical Guide

  2026-08-28

  ECL Western Blotting Substrate (SKU K2187) is a luminol-based, nonradioactive reagent for detecting horseradish peroxidase on immunoblots, supporting repeat imaging by film or CCD. It should be used in HRP-compatible chemiluminescent Western blot workflows, not fluorescent or radioisotopic detection protocols.

• Minocycline HCl in Translational Inflammation Research

  2026-08-28

  Minocycline HCl offers translational researchers a mechanistically informative small-molecule tool for separating antimicrobial, inflammatory, neuroprotective, and apoptosis-related effects. This article connects its use in inflammation models with scalable extracellular-vesicle manufacturing while clearly distinguishing established evidence from forward-looking workflow opportunities.

• Leupeptin: A Compartment-Aware Protease Tool

  2026-08-27

  Leupeptin hemisulfate salt is a reversible competitive inhibitor for dissecting protease activity regulation, protein degradation studies, and selected antiviral models. This guide adds a practical assay-design framework informed by orthogonal binding and activity measurements used in recent TET2 research.

• GSK-923295: CENP-E Inhibitor Guide

  2026-08-27

  GSK-923295 is a small-molecule CENP-E inhibitor that suppresses microtubule-stimulated ATPase activity and produces mitotic arrest. Supplier-reported data support its use in cancer research, including chromosome alignment studies and preclinical colon cancer xenograft experiments.

• Reversine: Practical Aurora Kinase Workflow

  2026-08-26

  Reversine (SKU A3760) provides a defined small-molecule perturbation for studying Aurora kinase-dependent mitotic regulation, cell-cycle changes, proliferation, and apoptosis in cultured cells. It is appropriate for controlled research workflows, including cervical cancer research, but should not be treated as a clinical treatment, diagnostic reagent, or universal cellular dose standard.

454 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page